Partial Gastrectomy-Windsor MEDBRICTlSJHRNAL cardia may well lead to the development of a hiatus hernia and account for the high incidence of this condition in the Billroth I group.
A further possible explanation of the findings is that there is a reduction in tone of the intrinsic sphincter mechanism of the lower oesophagus after partial gastrectomy. Clark and Vane (1961) showed that in animals the presence of alkali in the lower oesophagus reduces the tone in this sphincter, and it is thought that alkali in the oesophagus of post-gastrectomy patients reduces the efficiency of the gastro-oesophageal closing mechanism still further. Stammers and Williams (1963) have pointed out that iron absorption after partial gastrectomy is adequate for normal needs provided there is no occult loss. An attempt was made to correlate anaemia with radiological reflux. Iron deficiency and anaemia were present in as many patients with reflux as in those without, and no significant conclusions could be drawn from this small series. A more detailed study is planned to clarify this point. It is suggested, however, that oesophagitis after partial gastrectomy is a much more common condition than hitherto recognized and is a possible cause of loss of blood in the post-gastrectomy patient. Summary Sixty-one unselected patients were investigated after partial gastrectomy, and heartburn was found to be a complaint in 16 of them. Radiological reflux was induced in 24 patients-50% of the Biliroth I and 27% of the Polya cases. Hiatus hernia was present in only six patients. It is suggested that the symptoms are due to alkaline reflux with tryptic digestion of the oesophageal mucosa, and a mechanism is suggested for ts causation.
An attempt to correlate the symptoms of oesophagitis with post-gastrectomy anaemia was unsuccessful, though this is thought to be a likely association. The natural antibiotic, cephalosporin C, from which cephaloridine is derived, is produced by a strain of the mould Cephalosporium acremonium, which was isolated by Brotzu (1948) ; its structure was elucidated by Abraham and Newton (1961) . Though it is stable to acid and to penicillinase and is equally active against Gram-positive and Gram-negative organisms, its intrinsic activity is relatively low.
Replacement of the 7-a-aminoadipic acid side-chain of cephalosporin C with various substituted acetic acids gives compounds showing a marked increase in activity against Staphylococcus aureus and other Gram-positive organisms, but this type of substitution in general renders the acetoxy group at position 3 far more labile in the mammalian body (O'Callaghan and Muggleton, 1963) .
When the acetoxy group of cephalosporin C is replaced with pyridine or its analogues the resulting compounds have increased antibacterial activity (Hale, Newton, and and are, moreover, stable in the body (O'Callaghan and Muggleton, 1963 
Toxicology
An extensive study of the toxicity of cephaloridine will be reported elsewhere (Currie and Tomich, 1964 (Table I) Cephaloridine has a broad spectrum of activity, and sensitive organisms include Staph. aureus (including penicillin-resistant Cephaloridine is highly bactericidal in action, particularly against Gram-negative organisms, and addition at the minimum inhibitory concentration to a growing culture causes a rapid kill of the cells and then their lysis.
The development of resistance by strains of Staph. aureus takes place slowly, in small steps, and is independent of the sensitivity of the strains to penicillin. Cephaloridine is about 1,000 times more resistant to staphylococcal penicillinase than is penicillin V.
Antimicrobial Activity in vivo
Cephaloridine is highly effective in protecting mice against experimental Staph. aureus infections (Table II) . Six of the strains tested were highly resistant to penicillin. Cephaloridine is also active against a range of experimental infections with Gram-negative organisms in mice and protected the mice against all strains of E. coli, Pr. mirabilis, and Salmonella spp. tested at a median effective dose (ED50) of 25 mg./kg./dose or less. It has no activity in vivo against Ps. pyocyanea.
In general, cephaloridine is somewhat more active against Gram-negative organisms in this test than ampicillin and is consistently much better than tetracycline or chloramphenicol. It is also much more active against Staph. aureus than ampicillin, tetracycline, chloramphenicol, or methicillin.
Serum Levels and Urinary Excretion in Experimental Animals
Good serum levels, lasting for up to six hours, were obtained by intramuscular injection into rabbits, dogs, and monkeys, with peaks at about half an hour after injection. The urinary recovery, as measured in the rabbit, is good; on average 54 % of the dose given is recovered in 24 hours (see Table III 
Serum Levels and Urinary Excretion in Human Volunteers
Serum levels and urinary excretion of cephaloridine have been studied in human volunteers. Eight adult males received 250 mg. and 13 received 500 mg. by the intramuscular route in about 2 ml. of water for injection. Five received 1 g. by oral administration in rice-paper cachets.
The volunteers had a normal diet and a normal fluid intake during the tests. Those who received the substance orally did so about two and a half hours after a normal breakfast.
The injections were singularly painless. There were no complaints of pain either immediately after the injection or subsequently.
There were no signs of general malaise. Similarly, those who received 1 g. orally reported no toxic sideeffects. Urine samples taken from the volunteers before, during, and after the experiments were examined for the presence of albumin, sugar, and abnormal cellular or crystalline deposits (microscopical examination Serum samples, obtained by venepuncture at a, 1, 2, 4, 6, and 8 hours after administration, were separated and kept at 40 C. until they were assayed 4 to 16 hours later (Figs. 1 and 2) . Urine samples were collected over the periods 0-2, 2-4, 4-6, 6-12, 12-24 hours after administration. The results are given in Table IV. The urine samples were examined by chromatographs and bioautographs as well as by plate assay. No other microbiologically active metabolite of cephaloridine was observed, and it would appear that the substance is excreted unchanged.
Good levels of antibacterial activity were obtained in the serum after intramuscular administration of cephaloridine. The levels and their persistence agreed well with those obtained in rabbits, monkeys, and dogs. At a dose of 250 mg., the peak serum levels found at half to one hour cover the minimum inhibitory concentrations of most Staph. aureus strains 10 to 100 times. This dose also gave excellent antibiotic levels in the urine (400 to 1,000 jug./ml.) which would be expected to be effective against many Gram-negative organisms in the urinary tract. Higher serum levels were obtained after the 500-mg. dose. These were high enough to cover easily the minimum inhibitory concentrations against the more resistant staphylococci and also to cover a great many of the Gram-negative organisms. The recovery of the injected dose was at least 80%. Serum levels and urinary recovery after oral administration of a 1-g. dose were low, only about 1 % of the dose given being recovered in the urine. It was concluded that cephaloridine is only poorly absorbed when given by mouth.
Conclusions
Cephaloridine has a broad spectrum of activity in vitro and is highly effective in protecting experimentally infected mice against both penicillin-sensitive and penicillin-resistant strains of Staph. aureus, and against E. coli, Pr. mirabilis, and Salmonella spp. Protection is obtained at practicable dose levels (2 to 25 mg./kg./dose by subcutaneous injection), and in general the substance is more active than tetracycline, ampicillin, or chloramphenicol. It is very rapidly bactericidal.
Good serum levels are obtained when cephaloridine is injected intramuscularly into dogs, rabbits, or monkeys, with a peak at half to one hour. The substance is excreted efficiently by the kidney; from rabbits an average of 54% is recovered in the urine. No evidence of serum-binding was observed with either human or animal sera.
When cephaloridine is given intramuscularly to human volunteers, good peak serum levels are obtained at half to one hour, with activity lasting for eight hours. The peak serum concentrations are sufficient to cover the minimum inhibitory concentrations against most Staph. aureus strains 10 to 100 times. There was good urinary recovery of the dose given; also high concentrations were achieved in the urine (200 to 2,000 ptg./ml.). This, coupled with the highly bactericidal action of the antibiotic, suggests that treatment by it of Gramnegative infections in the urinary tract would be effective. The injections were well tolerated and were stated by the volunteers to be singularly free from pain; none of the volunteers experienced any untoward reactions.
Summary
Cephaloridine (Ceporin) is a new semisynthetic antibiotic derived from cephalosporin C.
It has a broad spectrum of activity in vitro, and is active against both penicillin-sensitive and penicillin-resistant strains of Staph. aureus. It is bactericidal in action.
It is highly effective in protecting experimentally infected mice against Staph. aureus, E. coli, Pr. mirabilis, and Salmonellaspp.
Good blood levels are attained in experimental animals after intramuscular injection.
Intramuscular injection of 250 and 500 mg. doses into human volunteers gave good serum levels, high urinary levels, good urinary recovery, and complete freedom from undesirable sideeffects.
